The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis

Various animal models showed that peroxisome proliferator-activated receptor (PPAR)γ agonists, when given as a gavage shortly preceding colitis induction, protect against inflammatory bowel disease (IBD). We have examined the effects of 16 days rosiglitazone treatment via the diet prior to dextran s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ramakers, Julian D., Verstege, Marleen I., Thuijls, Geertje, Te Velde, Anje A., Mensink, Ronald P., Plat, Jogchum
Formato: Artigo
Idioma:Inglês
Publicado em: Kluwer Academic Publishers-Plenum Publishers 2007
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1915631/
https://ncbi.nlm.nih.gov/pubmed/17510806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-007-9074-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados